Drug
ritlecitinib
Marketed as LITFULO.
Generic name
ritlecitinib
Brand names
LITFULO
First FDA approval
2023-06-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA215830 | LITFULO | 2023-06-23 | PFIZER |
Manufacturers
PFIZER
Frequently asked questions
When was ritlecitinib FDA approved?
Earliest FDA approval on record: 2023-06-23.
What brand names are sold as ritlecitinib?
LITFULO.
Sources
Appeal a ritlecitinib denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com